Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eli Lilly (LLY) CEO Lechleiter 'Disappointed,' after Alzheimer's Drug Fails
Eli Lilly (LLY) CEO Lechleiter 'Disappointed,' after Alzheimer's Drug Fails
Eli Lilly (LLY) CEO Lechleiter 'Disappointed,' after Alzheimer's Drug Fails
Submitted by
admin
on November 23, 2016 - 10:29am
Source:
TheStreet.com
News Tags:
Eli Lilly
Alzheimer's disease
clinical trials
solanezumab
John Lechleiter
Headline:
Eli Lilly (LLY) CEO Lechleiter 'Disappointed,' after Alzheimer's Drug Fails
Do Not Allow Advertisers to Use My Personal information
